Avidity Biosciences, Inc (RNAM) — Capital Reinvestment Ratio
Avidity Biosciences, Inc (RNAM) has a Capital Reinvestment Ratio of 0.05x as of December 2023, meaning it reinvests 0% of its operating cash flow ($16.50 Million) in capital expenditures ($863.00K). Check Avidity Biosciences, Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Avidity Biosciences, Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Avidity Biosciences, Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see RNAM operating cash flow.
Annual Capital Reinvestment Ratio for Avidity Biosciences, Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Avidity Biosciences, Inc from 2019 to 2019. See Avidity Biosciences, Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.09x | $2.49 Million | $235.00K | — |